PubMed

Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.

Niskanen L, Hedner T, Hansson L, Lanke J, Niklason A; CAPPP Study Group.

Diabetes Care. 2001 Dec;24(12):2091-6.PMID: 11723089 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial.

Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklason A, Luomanmäki K, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE.

Lancet. 1999 Feb 20;353(9153):611-6.PMID: 10030325 [PubMed - indexed for MEDLINE]Related articles

Influence of age, sex and blood pressure on the principal endpoints of the Nordic Diltiazem (NORDIL) Study.

Kjeldsen SE, Hedner T, Syvertsen JO, Lund-Johansen P, Hansson L, Lanke J, Lindholm LH, De Faire U, Dahlöf B, Karlberg BE; NORDIL Study Group.

J Hypertens. 2002 Jun;20(6):1231-7.PMID: 12023696 [PubMed - indexed for MEDLINE]Related articles

Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.

Ekbom T, Linjer E, Hedner T, Lanke J, De Faire U, Wester PO, Dahlöf B, Scherstén B.

Blood Press. 2004;13(3):137-41.PMID: 15223721 [PubMed - indexed for MEDLINE]Related articles

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Hansson L, Hedner T, Lund-Johansen P, Kjeldsen SE, Lindholm LH, Syvertsen JO, Lanke J, de Faire U, Dahlöf B, Karlberg BE.

Lancet. 2000 Jul 29;356(9227):359-65.PMID: 10972367 [PubMed - indexed for MEDLINE]Related articles

Development of diabetes is retarded by ACE inhibition in hypertensive patients--a subanalysis of the Captopril Prevention Project (CAPPP).

Niklason A, Hedner T, Niskanen L, Lanke J; Captopril Prevention Project Study Group.

J Hypertens. 2004 Mar;22(3):645-52.PMID: 15076172 [PubMed - indexed for MEDLINE]Related articles

[Clinical study of the month. The CAPPP study: "The Captopril Prevention Project"]

Scheen AJ.

Rev Med Liege. 1999 Mar;54(3):197-9. French. PMID: 10321112 [PubMed - indexed for MEDLINE]Related articles

Association between cardiovascular outcomes and antihypertensive drug treatment in older women.

Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.

JAMA. 2004 Dec 15;292(23):2849-59. Erratum in: JAMA. 2005 Apr 6;293(13):1594. PMID: 15598916 [PubMed - indexed for MEDLINE]Related articlesFree article

Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes.

Pahor M, Psaty BM, Alderman MH, Applegate WB, Williamson JD, Furberg CD.

Diabetes Care. 2000 Jul;23(7):888-92.PMID: 10895836 [PubMed - indexed for MEDLINE]Related articlesFree article

Evidence-based evaluation of calcium channel blockers for hypertension: equality of mortality and cardiovascular risk relative to conventional therapy.

Opie LH, Schall R.

J Am Coll Cardiol. 2002 Jan 16;39(2):315-22. Erratum in: J Am Coll Cardiol 2002 Apr 17;39(8):1409-10. PMID: 11788225 [PubMed - indexed for MEDLINE]Related articles

Controversies surrounding the treatment of the hypertensive patient with diabetes.

Prisant LM, Louard RJ.

Curr Hypertens Rep. 1999 Dec;1(6):512-20.PMID: 10981115 [PubMed - indexed for MEDLINE]Related articles

Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.

Black HR, Elliott WJ, Grandits G, Grambsch P, Lucente T, White WB, Neaton JD, Grimm RH Jr, Hansson L, Lacourciere Y, Muller J, Sleight P, Weber MA, Williams G, Wittes J, Zanchetti A, Anders RJ; CONVINCE Research Group.

JAMA. 2003 Apr 23-30;289(16):2073-82.PMID: 12709465 [PubMed - indexed for MEDLINE]Related articlesFree article

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.

JAMA. 2002 Dec 18;288(23):2981-97. Erratum in: JAMA 2003 Jan 8;289(2):178. JAMA. 2004 May 12;291(18):2196. PMID: 12479763 [PubMed - indexed for MEDLINE]Related articlesFree article

Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.

[No authors listed]

JAMA. 2000 Apr 19;283(15):1967-75. Erratum in: JAMA 2002 Dec 18;288(23):2976. PMID: 10789664 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of angiotensin-converting enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPP) randomized trial. The Captopril Prevention Project (CAPP) Study Group.

[No authors listed]

Curr Hypertens Rep. 1999 Dec;1(6):466-7. No abstract available. PMID: 11041675 [PubMed - indexed for MEDLINE]Related articles

Efficacy of diuretics and beta-blockers in diabetic hypertensive patients. Results from a meta-analysis. The INDANA Steering Committee.

Lièvre M, Gueyffier F, Ekbom T, Fagard R, Cutler J, Schron E, Marre M, Boissel JP.

Diabetes Care. 2000 Apr;23 Suppl 2:B65-71.PMID: 10860193 [PubMed - indexed for MEDLINE]Related articles

The Captopril Prevention Project (CAPPP) in hypertension--baseline data and current status.

Hansson L, Hedner T, Lindholm L, Niklason A, Luomanmäki K, Niskanen L, Lanke J, Dahlöf B, de Faire U, Mörlin C, Karlberg BE, Wester PO, Björck JE.

Blood Press. 1997 Nov;6(6):365-7.PMID: 9495662 [PubMed - indexed for MEDLINE]Related articles

Health outcomes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis.

Psaty BM, Lumley T, Furberg CD, Schellenbaum G, Pahor M, Alderman MH, Weiss NS.

JAMA. 2003 May 21;289(19):2534-44.PMID: 12759325 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of early treatment with captopril and metoprolol singly or together on six-month mortality and morbidity after acute myocardial infarction. Results of the RIMA (Rimodellamento Infarto Miocardico Acuto) study. The RIMA researchers.

Coletta C, Ricci R, Ceci V, Seccareccia F, Rulli F, Mazzuca V, Putini RL, Salustri A, Bottero G, Pasquale M.

G Ital Cardiol. 1999 Feb;29(2):115-24; discussion 125-9.PMID: 10088066 [PubMed - indexed for MEDLINE]Related articles

Outcomes in hypertensive black and nonblack patients treated with chlorthalidone, amlodipine, and lisinopril.

Wright JT Jr, Dunn JK, Cutler JA, Davis BR, Cushman WC, Ford CE, Haywood LJ, Leenen FH, Margolis KL, Papademetriou V, Probstfield JL, Whelton PK, Habib GB; ALLHAT Collaborative Research Group.

JAMA. 2005 Apr 6;293(13):1595-608.PMID: 15811979 [PubMed - indexed for MEDLINE]Related articlesFree article